iCAD Reports Third Quarter 2017 Financial Results
Total revenues increased 17% year-over-year; up 29%
excluding MRI asset sale
Conference Call today at 4:30 p.m. ET
NASHUA, N.H. (November 8, 2017) – iCAD, Inc. (NASDAQ: ICAD),
an industry-leading provider of advanced image analysis, workflow solutions and
radiation therapy for the early identification and treatment of cancer, today
reported financial results for the three and nine months ended September 30,
2017.